Back Close
Agenda

VARN2022: Shaping Global Vaccine Acceptance with Localized Knowledge

Registration for the conference is currently closed. If you have any questions, please contact vaccineacceptance@sabin.org.
Download the agenda

DAY 1, March 1, 2022

SESSION I @ 8-9:30 a.m. EST: WELCOME & KEYNOTE ADDRESS (LIVE)

Welcoming Remarks by Stacey Knobler, MSc, Vice President, Vaccine Innovation & Global Immunization, Sabin Vaccine Institute

Introduction of the VARN: Goals & Objectives

  • Dr. Kate Hopkins, PhD, MPH, Director of Research, Vaccine Acceptance & Demand, Sabin Vaccine Institute
  •  Dr. Ève Dubé, PhD, Medical Anthropologist, Quebec National Institute of Public Health, Canada

Keynote Address by Robert Kanwagi, MPH, Consultant for Gavi, the Vaccine Alliance – Demand Generation for COVAX: Understanding Vaccine Acceptance: Why It Matters, How It’s Differentiated and Key Drivers

Keynote Discussion Panel, 30 minutes

Moderator: Dr. Ève Dubé, PhD, Quebec National Institute of Public Health, Canada

Panelists:

  • Robert Kanwagi, MPH, Consultant for Gavi, the Vaccine Alliance – Demand Generation for COVAX
  • Dr. Holly Seale, PhD, MPH, School of Population Health, University of New South Wales, Australia
  • Dr. Abdul Momin Kazi, MBBS, MPH, Aga Khan University Department of Paediatrics and Child Health, Pakistan
  • Dr. Mónica Berger González , PhD, Unit of Medical Anthropology in the Center for Health Studies at Universidad del Valle de Guatemala

Moderated Audience Q&A, 20 minutes

 

SESSION II @3-4:30 p.m. EST: One Size Does Not Fit All: Indicators of Vaccine Acceptance and Uptake from around the Globe

Moderator: Dr. Holly Seale, PhD, MPH, School of Population Health, University of New South Wales, Australia

Presentation Panelists

  • Dr. Ève Dubé, PhD, Quebec National Institute of Public Health, Canada: COVID-19 Vaccine Acceptance in Quebec, Canada: Findings of Repeated Surveys Conducted Across 5 Waves
  • Philip Wollburg, MSc, Data Production and Methods Unit, World Bank: Attitudes Towards COVID-19 Vaccination in Africa
  • Dr. Ahmed Mushfiq Mobarak, PhD, MAYale University School of Management, USA: Last-Mile Delivery of COVID vaccines: Field Trials in Sierra Leone, Bangladesh, and India
    • Niccoló F. Meriggi, MSc, International Growth Centre Sierra Leone, will join us on the live panel on behalf of Dr. Mobarak
  • Lisa Menning, MScWorld Health Organization Headquarters Department of Immunization, Vaccines, and Biologicals: The WHO Behavioral and Social Drivers (BeSD) Framework
  • Helena Ballester Bon, MAUNICEF Eastern and Southern Africa Regional Office, Social and Behavior Change Section: Measuring BeSD of COVID-19 Vaccination, UNICEF Application of Globally Standardized Data Collection Tools in Eastern and Southern Africa
  • Claire Thomas, BSc, Minority Rights Group International: Disparities in Access to Routine Childhood Vaccinations: Investigating Correlations with Diversity of Ethnicity, Language and Religion

Moderated Audience Q&A, 20 minutes

 

SESSION III @ 8-9:30 p.m. EST: Harnessing Social Media for Public Good: Lessons Learned from Social Listening on Social Media/Messaging

Moderator: Dr. Margie Danchin, MBBS, PhDUniversity of Melbourne Department of Paediatrics, Australia 

Presentation Panelists

  • Dr. Daniel Erchick, PhD, MPH, Johns Hopkins Bloomberg School of Public Health, USA: What Message Appeals are Most Persuasive to Nudge Vaccine-Hesitant Individuals to Accept a Vaccine?
  • Dr. Rajiv Rimal, PhD, MA, Johns Hopkins Bloomberg School of Public Health, USA: Promoting the Second Dose of the Covid-19 Vaccine in Odisha, India: The Role of Humor, Collectivistic Appeal, and Gender
  • Dr. Silvia Sommariva, PhD, UNICEF Eastern and Southern Africa Regional Office, Social and Behavior Change: Online Conversations on COVID-19 Vaccines in Eastern and Southern Africa: A Longitudinal Analysis of Social Listening Data
  • Jeff Mulhausen, BS, Upstream Thinking: Redirecting Existing Demand for Information Towards Vaccine Confident Interpretation by Identifying Online Behavioral Nudge Interventions
  • Rose Weeks, MPHJohns Hopkins Bloomberg School of Public Health, USA: Building Rapport and Credibility with an AI Chatbot
  • Dr. Naor Bar-Zeev, MBBS, PhD, MPH, Johns Hopkins Bloomberg School of Public Health, USA: Supporting Immunization Systems Through Chatbot-Powered Social Listening

Moderated Audience Q&A, 20 minutes


DAY 2, March 2, 2022

SESSION I @ 5-6:30 a.m. EST: Fighting the Infodemic: Frameworks, Training and Science-based Gaming

Moderator: Dr. Abdul Momin Kazi, MBBS, MPH, Aga Khan University Department of Paediatrics and Child Health, Pakistan

Presentation Panelists

  • Tina Purnat, MS, World Health Organization Department of Epidemic and Pandemic Preparedness and Prevention: WHO Preparedness and Prevention of Infodemic Harms: Infodemic Management Training Programme
  • Alexandra Michel, MPH, Johns Hopkins Bloomberg School of Public Health, USA: How Does Training Focused on Equipping Individuals with Skills to Identify and Reject Vaccine Misinformation Affect Vaccine Information Seeking?
  • Dr. John Cook, PhD, Monash University Climate Change Communication Research Hub, Australia: Using Gamification to Combat Misinformation: Cranky Uncle, Vaccine Module
  • Dr. David Scales, MD, PhD, Weill Cornell Medicine Division of Hospital Medicine, USA: Evaluation of a Geographic, Community-Focused Infodemiology Intervention Addressing COVID-19 Vaccine Misinformation on Social Media Using an Implementation Science Framework

Moderated Discussion, 20 minutes

 

SESSION II @ 9-10:30 a.m. EST: Cross Pollination and Translational Research: Moving Findings into Policy & Practice

Moderator: Nalini Anand, JD, MPH, Fogarty International Center, U.S. National Institutes of Health

Presentation Panelists

  • Dr. Rajeev Seth, MD, MBBS, Bal Umang Drishya Sanstha (BUDS), India: Translating BUDS Findings Into Local Policy and Advocacy
  • Ashima Gulati, B.A., LLB (Hons.) and Avani Airan, B.A., LLB (Hons.), #HumHongeKaamayaab, India: Vaccination Uptake in Marginalised Communities in India: An Analysis of Government and Civil Society Interventions to Address the Gender and Economic Divide in Accessing Free COVID-19 Vaccines
  • Dr. Janan Dietrich, PhD, Bio-Behavioural Research Division Perinatal HIV Research Unit, South Africa: Translating lessons of HIV vaccine acceptance to COVID-19 vaccines among youth in South Africa
  • Dr. Corrina Moucheraud, ScD, MPH, University of California Los Angeles Fielding School of Public Health, USA: Barriers Towards HPV Vaccine Acceptance in Malawi
  • Dr. Susanne B Montgomery, PhD, MPH, MS, Loma Linda University School of Behavioral Health, USA: The Community Resiliency Model and How It Could Translate to Combatting Vaccine Hesitancy in Sierra Leone and Beyond
  • Dr. Rupali Limaye, PhD, MPH, MA, Johns Hopkins Bloomberg School of Public Health, USA: What Can We Learn from Climate Change Misinformation to Inform Vaccine Hesitancy Strategies?

Moderated Audience Q&A, 20-30 minutes

 

SESSION III @ 1-2:30 p.m. EST: Boosting Vaccination Rates: Efficiently Informing Mass Vaccination Campaigns

Moderator: Dr. Wahdae-mai Harmon-Gray, MD, MScUniversity of Liberia College of Health Sciences

Presentation Panelists

  • Dr. Dena Gromet, PhD, University of Pennsylvania Behavior Change for Good Initiative: Behaviour Change for Good: Effective Strategies to Boost Vaccination Rates
  • Sunny Sharma, MSc, Ipsos MORI: Using Attitudinal Segmentation to Support Public Health Initiatives in sub-Saharan Africa: Case studies in Kenya, Nigeria and Zambia
  • Kenneth Davis, MA, Fraym: Using Geomapping Data Analytics to Assist Governments in Tailoring Mass Vaccination Campaigns
  • Dr. Ruth Carlitz, PhD, Tulane University, Department of Political Science, USA and Dr. Thespina Yamanis, PhD, MPH, American University, School of International Service, USA: Challenges to and Opportunities for Rolling Out the COVID-19 Vaccine in Tanzania
  • Sofia Imad, MPH, Artha Global, India: Vaccine Acceptance in Urban Slum Communities in Maharashtra

Moderated Discussion Panel, 20 minutes

Moderated Audience Q&A, 20 minutes


DAY 3, March 3, 2022

SESSION I @ 8-10 a.m. EST. One Size Does Not Fit All: Community-centric Approaches to Promote Vaccine Acceptance & Uptake

Moderator: Dr. Chizoba Wonodi, MBBS, DrPH, MPH, Women Advocates for Vaccine Access (WAVA), Nigeria

Presentation Panelists

  • Baldeep Dhaliwal, MSPH, Johns Hopkins Bloomberg School of Public Health, USA: Establishing an Understanding of Community-Level Misinformation and the Role of Community Health Workers in Vaccine Acceptance in India
  • Rubina Qasim, MSc, Institute of Nursing, Dow University of Health Sciences, Pakistan: Using a Co-Design Approach in Designing and Testing Socio-Behavioural Interventions to Counter COVID-19 Related Misinformation and its Impact on Potential COVID-19 Vaccination in Karachi, Pakistan
  • Dr. Freddy Kitutu, PhD, MPH, MA, School of Health Sciences, Makerere University, Uganda: Using Community Influencer Groups to Address COVID-19 Misinformation and Vaccine Hesitancy in Buikwe, Uganda
  • Dr. Benson Wamalwa, PhD, MSc and Dr. Caroline Aura, PhDUniversity of Nairobi, Kenya: A Community-led Virtual Intervention to Mitigate COVID-19 Misinformation and Increase COVID-19 Vaccine Acceptance in Kenya
  • Dr. Abdul Momin Kazi, MBBS, MPH, Aga Khan University Department of Pediatrics and Child Health in Karachi: To Explore the Role of mHealth Based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan
  • Dr. Nadine Ann Skinner, PhD, MPA, Stanford Center for Health Education, Digital Medic, USA and Anne Kraemer Diaz, MA, Maya Health Alliance: Understanding Vaccine Acceptance in Indigenous Populations in Southern Guatemala
  • Dr. Nadia Diamond-Smith, PhD, MSc, Department of Epidemiology and Biostatics and Institute for Global Health Sciences at the University of California San Francisco, USA and Dr. Preetika Sharma, PhD, Postgraduate Institute of Medical Education and Research, India: Why are Pregnant and Breastfeeding Women in Rural India Who Want the COVID-19 Vaccine Not Getting Vaccinated?

Moderated Discussion, 20 minutes

Moderated Audience Q&A, 10 minutes

 

SESSION II @ 1-2:30 p.m. EST. Technical Working Group Breakout Sessions (LIVE)

Brief Introduction to the Technical Working Groups by Dr. Kate Hopkins, PhD, MPH, Director of Research, Vaccine Acceptance & Demand, Sabin Vaccine Institute

Technical Working Group Breakout Sessions 

Learn more about the TWG topics. You can select a TWG during registration or opt-in at the start of the session. 

  • Community-Centric Methods to Support Marginalized & Hard-to-Reach Populations
    • Co-Chairs: Dr. Ève Dubé, PhDMedical Anthropologist, Quebec National Institute of Public Health, VARN Chair &  Robert Kanwagi, MPH, Consultant for Gavi, the Vaccine Alliance – Demand Generation for COVAX
  • Fighting the Infodemic & Harnessing Social Media for Good
    • Co-Chairs: Dr. Rupali Limaye, PhD, MPH, MA, Associate Scientist, Johns Hopkins Bloomberg School of Public Health & Dr. Angus Thomson, PhD, Senior Social Scientist, Consultant for UNICEF – Demand for Immunization
  • Data Integrity & the Evaluation of Best Practices
    • Co-Chairs: Sunny Sharma, MSc, Director of Global Health, Ipsos MORI & Dr. Kennedy Otwombe, PhD, Director of Statistics, Perinatal HIV Research Unit, University of the Witwatersrand, South Africa
  • Supporting Communities of Practice Networks & Platforms
    • Co-Chairs: Stacey Knobler, MSc, Vice President of Vaccine Innovation and Global Immunization, Sabin Vaccine Institute and Dr. Anant Bhan, MBBS, MHSc, Adjunct (Visiting) Professor in the Department of Community Medicine, Yenepoya Medical College and the Centre for Ethics, Yenepoya University, Mangalore

 

SESSION III @ 11 p.m. – 12:30 a.m. EST.  Closing Session (LIVE)

Moderator: Dr. Kate Hopkins, PhD, MPH, Sabin Vaccine Institute

Read-out from Working Groups

  • Baldeep Dhaliwal, MSPHJohns Hopkins Bloomberg School of Public Health: Community-Centric Methods to Support Marginalized & Hard-to-Reach Populations
  • Rubina Qasim, MSc, Institute of Nursing, Dow University of Health Sciences, Pakistan: Fighting the Infodemic & Harnessing Social Media for Good
  • Dr. Theresa Sommers, PhD, MPH, Sabin Vaccine Institute: Data Integrity & Evaluation of Best Practices
  • Dr. Anant Bhan, MBBS, MHSc,  Principal Investigator, Sangath, Bhopal, India and Adjunct (Visiting) Professor, Centre for Ethics, Yenepoya University, Mangalore, India: Supporting Communities of Practice Networks & Platforms

Highlights & Closing Remarks: Stacey Knobler, MSc, Sabin Vaccine Institute


ADDITIONAL CONCOMMITANT & EXTENDED VIRTUAL POSTER SESSIONS: Posters with audio recorded summaries will be displayed, falling within the following themes: community-centric methods, social media/listening & mHealth, marginalized populations, and case studies.

A RESOURCE HALL AND VARN2022 ATTENDEE DIRECTORY will be provided to share additional Sabin and VARN member knowledge and encourage virtual networking.